高齢者評価による管理介入 (GAIN-S) が予後認識に与える影響:ランダム化制御試験
Cristiane Decat Bergerot1, Paulo Gustavo Bergerot1, Marianne Razavi2
1Oncoclinicas & Co, Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil.
Cancer
|August 21, 2025
まとめ
高齢診断 (GA) によるサポートケア (GAIN- S) は,転移性がんの高齢者における予後認識の感情的および適応的側面を改善しました. この介入は 患者に不確実性を克服し 苦痛を軽減するのに役立ちます
科学分野:
- 老年腫瘍学
- 緩和ケア
- 臨床試験の研究
背景:
- 高齢者評価 (GA) によるサポートケア (GAIN-S) は,がんを患っている高齢者の意思決定を向上させる可能性があります.
- この集団における予後意識に対するGAIN-Sの影響は,まだ十分に研究されていない.
研究 の 目的:
- GAIN-Sが転移した癌の高齢者の予後認識を改善するかどうかを評価する.
- 予後意識の感情的,適応的,認知的領域に GAIN-S の影響を評価する.
主な方法:
- ランダム化比較試験はブラジルで実施され,65歳以上で転移したがんを患った成人を対象とした.
- 参加者はGAIN- S (n=39) または通常の治療 (UC,n=38) にランダムに割り当てられました.
- 予測意識は,感情的,適応的,認知的な側面を評価する予測意識インパクトアンケートを使用して測定されました.
主要な成果:
- GAIN- SはUCと比較して,予後意識の感情的 (p=. 002) と適応的 (p=. 008) 領域を有意に改善した.
- 認知領域では有意な差異は見つかりませんでした.
- GAIN-Sの参加者は,予後不確実性,感情的受容性,および減少した苦悩をうまく対処したと報告しました.
結論:
- GAIN- Sの介入は,転移した癌の高齢者の感情的および適応的予後意識を効果的に高めます.
- これらの発見は,患者の健康を改善するためのGAIN-Sの価値を強調しています.
- 意思決定,コミュニケーション,生活の質に及ぼす長期的な影響を調査するためにさらなる研究が必要です.
さらに関連する動画
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.8K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
関連する概念動画
01:26Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23